Carboprost Tromethamine Injection, Solution
Product Images NDC 25021-477

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carboprost Tromethamine (NDC 25021-477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Car16 0000 01)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Car16 0000 02)

Package Label – Principal Display Panel – Vial Label (Car16 0000 02)
This text provides information about Carboprost, an injection with a concentration of 250 mcg per mL. It is designated for intramuscular use only, and each single-dose vial contains 1 mL equivalent to 250 mcg of carboprost. The product should be stored between 2° and 8°C. The manufacturer is SAGENT Pharmaceuticals, located in Schaumburg, IL, with production in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.